Millipore Sigma Vibrant Logo

400050 Hygromycin B, Streptomyces sp., Cell Culture-Tested - CAS 31282-04-9 - Calbiochem

Unique aminoglycoside antibiotic that inhibits the growth of prokaryotic (bacteria) and eukaryotic microorganisms (yeasts) and mammalian cells.

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
View Products on Sigmaaldrich.com
400050
  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
—
Request Pricing
—
Limited Availability Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

       

      Contact Customer Service

      Overview

      Replacement Information

      Key Spec Table

      CAS #Empirical Formula
      31282-04-9C₂₀H₃₇N₃O₁₃
      Description
      OverviewUnique aminoglycoside antibiotic that inhibits the growth of prokaryotic (bacteria) and eukaryotic microorganisms (yeasts) and mammalian cells. Inhibits protein synthesis at the translocation step on the 70S ribosome and causes misreading of the mRNA. Hph, a gene from E. coli, encodes resistance to hygromycin B and can be isolated and cloned by recombinant DNA techniques. This hygromycin B-resistance gene is particularly useful for the identification or selection of recombinant clones in a variety of cell types. Hygromycin B penetrates cells that have been permeabilized by virus infection and can act as an effective antiviral agent. Working concentration: 50 µg/ml - 1 mg/ml for mammalian cell selection.
      Potency: ≥1000 µ/mg solid.
      Catalogue Number400050
      Brand Family Calbiochem®
      References
      ReferencesDean, N. 1995. Proc. Natl. Acad. Sci. USA 92, 1287.
      Hubbard, S. C., et al. 1994. J. Biol. Chem. 269, 3717.
      Rikkerink, E. H., et al. 1994. Current Genetics 25, 202.
      Sugimoto, K., et al. 1994. Plant J. 5, 863.
      MacIntyre, G., et al. 1992. Adv. Exp. Med. Biol. 276, 67.
      Bilang, R., et al. 1991. Gene 100, 247.
      Lee, M.G-S., and Van der Ploeg, L. 1991. Gene 105, 255.
      Leslie, J.F., and Dickman, M.B. 1991. Applied Environ. Microbiol. 57, 1423.
      MacIntyre, G., et al. 1991. Antimicrob. Agents Chemother. 35, 2125.
      Zhou, J., et al. 1991. Gene 107, 307.
      Bulte, L., and Bennoun, P. 1990. Current Genetics 18, 155.
      Giordano, T.J., and McAllister, W.T. 1990. Gene 88, 285.
      Salauze, D., et al. 1990. Antimicrob. Agents Chemother. 24, 1915.
      Carrasco, L., et al. 1989. Pharmacol. Ther. 9, 311.
      Crespi, C.L., et al. 1989. Carcinogenesis 10, 295.
      Damm, B., et al. 1989. Mol. Gen. Genetics 217, 6.
      Egelhoff, T.T., et al. 1989. Mol. Cell. Biol. 9, 1965.
      Kronstad, J.W., et al. 1989. Gene 79, 97.
      Perlin, D.S., et al. 1988. J. Biol. Chem. 263, 118.
      Cullen, D., et al. 1987. Gene 57, 21.
      Gonzalez, A., et al. 1978. Biochim. Biophys. Acta 521, 459.
      Malpartida, F., et al. 1983. Biochem. Biophys. Res. Commun. 117, 6.
      Rao, S.N., et al. 1983. Antimicrob. Agents Chemother. 24, 689.
      Product Information
      CAS number31282-04-9
      FormLight brown lyophilized solid
      Hill FormulaC₂₀H₃₇N₃O₁₃
      Chemical formulaC₂₀H₃₇N₃O₁₃
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Application CommentsProvided as a light brown lyophilized solid. Not provided under sterile conditions. If a sterile solution is desired, working solutions of Hygromycin B in aqueous media can be passed through a 0.2 micron filter before use.
      Biological Information
      Biological activityThe activity of Hygromycin B is measured in a zonal inhibition assay using Bacillus subtilis. The activity is measured relative to a reference standard.
      Purity≥90% by HPLC and TLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSWK2130000
      Safety Information
      R PhraseR: 26/27/28-37/38-41

      Very toxic by inhalation, in contact with skin and if swallowed.
      Irritating to respiratory system and skin.
      Risk of serious damage to eyes.
      S PhraseS: 22-26-36/37/39-45

      Do not breathe dust.
      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Wear suitable protective clothing, gloves and eye/face protection.
      In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Highly Toxic & Carcinogenic / Teratogenic
      Hazardous Materials Attention: Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
      Storage +2°C to +8°C
      Do not freeze Ok to freeze
      Special InstructionsAqueous stock solutions should be kept at concentrations of ≥50 mg/ml and can be stored at either 4°C or -20°C. Aqueous stock solutions (≥50 mg/ml) are stable for up to 6 months at 4°C or -20°C. Working solutions (< 2 mg/ml) are stable for up to 1 month at 4°C.

      Note: This product is highly toxic. Read enclosed MSDS before handling.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      400050 0

      Documentation

      Hygromycin B, Streptomyces sp., Cell Culture-Tested - CAS 31282-04-9 - Calbiochem SDS

      Title

      Safety Data Sheet (SDS) 

      Hygromycin B, Streptomyces sp., Cell Culture-Tested - CAS 31282-04-9 - Calbiochem Certificates of Analysis

      TitleLot Number
      400050

      References

      Reference overview
      Dean, N. 1995. Proc. Natl. Acad. Sci. USA 92, 1287.
      Hubbard, S. C., et al. 1994. J. Biol. Chem. 269, 3717.
      Rikkerink, E. H., et al. 1994. Current Genetics 25, 202.
      Sugimoto, K., et al. 1994. Plant J. 5, 863.
      MacIntyre, G., et al. 1992. Adv. Exp. Med. Biol. 276, 67.
      Bilang, R., et al. 1991. Gene 100, 247.
      Lee, M.G-S., and Van der Ploeg, L. 1991. Gene 105, 255.
      Leslie, J.F., and Dickman, M.B. 1991. Applied Environ. Microbiol. 57, 1423.
      MacIntyre, G., et al. 1991. Antimicrob. Agents Chemother. 35, 2125.
      Zhou, J., et al. 1991. Gene 107, 307.
      Bulte, L., and Bennoun, P. 1990. Current Genetics 18, 155.
      Giordano, T.J., and McAllister, W.T. 1990. Gene 88, 285.
      Salauze, D., et al. 1990. Antimicrob. Agents Chemother. 24, 1915.
      Carrasco, L., et al. 1989. Pharmacol. Ther. 9, 311.
      Crespi, C.L., et al. 1989. Carcinogenesis 10, 295.
      Damm, B., et al. 1989. Mol. Gen. Genetics 217, 6.
      Egelhoff, T.T., et al. 1989. Mol. Cell. Biol. 9, 1965.
      Kronstad, J.W., et al. 1989. Gene 79, 97.
      Perlin, D.S., et al. 1988. J. Biol. Chem. 263, 118.
      Cullen, D., et al. 1987. Gene 57, 21.
      Gonzalez, A., et al. 1978. Biochim. Biophys. Acta 521, 459.
      Malpartida, F., et al. 1983. Biochem. Biophys. Res. Commun. 117, 6.
      Rao, S.N., et al. 1983. Antimicrob. Agents Chemother. 24, 689.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision26-September-2007 JSW
      DescriptionHygromycin B, an aminoglycoside antibiotic, inhibits the growth of prokaryotic and eukaryotic microorganisms and mammalian cells. Specifically, it inhibits protein synthesis by interfering with translocation of the 70S ribosome and inducing misreading of the mRNA template (Dean, N., Gonzalez, A., et al., Rao, S.N., et al.). Hygromycin B has been used to select mutants in a wide variety of cells including bacteria (Bilang, R., et al., Salauze, D., et al.), protozoans (Lee, M.G-S., and Van der Ploeg, L.H.T.), yeast (Perlin, D.S., et al.), fungi (Cullen, D., et al., Kronstad, J.W., et al., Egelhoff, T.T., et al., Leslie, J.F., and Dickman, M.B., Bulte, L., and Bennoun, P.), plants (Dean, N., Damm, B., et al., Rikkerink, E. H., et al., Sugimoto, K., et al.), and mammalian cells (Crespi, C.L., et al., Giordano, T.J., and McAllister, W.T., Hubbard, S. C., et al.).

      Resistance to Hygromycin B is conferred by a gene coding for a phosphotransferase that phosphorylates Hygromycin B, thereby inactivating it (Bilang, R., et al., Malpartida, F., et al.). Hygromycin B is known to selectively penetrate cells that have been rendered permeable by virus infection. This, combined with its potency in inhibiting translation, makes it an effective antiviral agent (MacIntyre, G., et al., Zhou, J., et al.).

      The analytical data listed below will vary from lot to lot.

      Appearance: Off-white to light brown solid
      Bioassay: 1000 U/mg
      Solubility: ≥100 mg/ml in H2O
      Purity (HPLC): ≥90%
      Cytotoxicity: Tested in HeLa and/or CHO cells
      BackgroundHygromycin B, an aminoglycoside antibiotic, inhibits the growth of prokaryotic and eukaryotic microorganisms and mammalian cells. Specifically, it inhibits protein synthesis by interfering with translocation of the 70S ribosome and inducing misreading of the mRNA template. Hygromycin B has been used to select mutants in a wide variety of cells including bacteria, protozoans, yeast, fungi, plants, and mammalian cells. Resistance to Hygromycin B is conferred by a gene coding for a phosphotransferase that phosphorylates Hygromycin B, thereby inactivating it. Hygromycin B is known to selectively penetrate cells that have been rendered permeable by virus infection. This combined with its potency in inhibiting translation, makes it an effective antiviral agent.
      FormLight brown lyophilized solid
      Recommended reaction conditions
      Hygromycin B is not provided under sterile conditions. If a sterile solution is desired, working solutions of Hygromycin B in aqueous media can be passed through a 0.2 µm filter before use. When using this product for mammalian cell selection the working concentration is generally between 50 µg/ml and 1 mg/ml. The appropriate concentration for use must be determined empirically for each cell type.
      CAS number31282-04-9
      RTECSWK2130000
      Chemical formulaC₂₀H₃₇N₃O₁₃
      Structure formulaStructure formula
      Purity≥90% by HPLC and TLC
      Biological activityThe activity of Hygromycin B is measured in a zonal inhibition assay using Bacillus subtilis. The activity is measured relative to a reference standard.
      SolubilitydH₂O (≥100 mg/ml)
      CommentsProvided as a light brown lyophilized solid. Not provided under sterile conditions. If a sterile solution is desired, working solutions of Hygromycin B in aqueous media can be passed through a 0.2 micron filter before use.
      Storage +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsAqueous stock solutions should be kept at concentrations of ≥50 mg/ml and can be stored at either 4°C or -20°C. Aqueous stock solutions (≥50 mg/ml) are stable for up to 6 months at 4°C or -20°C. Working solutions (< 2 mg/ml) are stable for up to 1 month at 4°C.

      Note: This product is highly toxic. Read enclosed MSDS before handling.
      Toxicity Highly Toxic & Carcinogenic / Teratogenic
      Merck USA index14, 4852
      ReferencesDean, N. 1995. Proc. Natl. Acad. Sci. USA 92, 1287.
      Hubbard, S. C., et al. 1994. J. Biol. Chem. 269, 3717.
      Rikkerink, E. H., et al. 1994. Current Genetics 25, 202.
      Sugimoto, K., et al. 1994. Plant J. 5, 863.
      MacIntyre, G., et al. 1992. Adv. Exp. Med. Biol. 276, 67.
      Bilang, R., et al. 1991. Gene 100, 247.
      Lee, M.G-S., and Van der Ploeg, L. 1991. Gene 105, 255.
      Leslie, J.F., and Dickman, M.B. 1991. Applied Environ. Microbiol. 57, 1423.
      MacIntyre, G., et al. 1991. Antimicrob. Agents Chemother. 35, 2125.
      Zhou, J., et al. 1991. Gene 107, 307.
      Bulte, L., and Bennoun, P. 1990. Current Genetics 18, 155.
      Giordano, T.J., and McAllister, W.T. 1990. Gene 88, 285.
      Salauze, D., et al. 1990. Antimicrob. Agents Chemother. 24, 1915.
      Carrasco, L., et al. 1989. Pharmacol. Ther. 9, 311.
      Crespi, C.L., et al. 1989. Carcinogenesis 10, 295.
      Damm, B., et al. 1989. Mol. Gen. Genetics 217, 6.
      Egelhoff, T.T., et al. 1989. Mol. Cell. Biol. 9, 1965.
      Kronstad, J.W., et al. 1989. Gene 79, 97.
      Perlin, D.S., et al. 1988. J. Biol. Chem. 263, 118.
      Cullen, D., et al. 1987. Gene 57, 21.
      Gonzalez, A., et al. 1978. Biochim. Biophys. Acta 521, 459.
      Malpartida, F., et al. 1983. Biochem. Biophys. Res. Commun. 117, 6.
      Rao, S.N., et al. 1983. Antimicrob. Agents Chemother. 24, 689.